Paul T Quinlan

Paul T Quinlan has an estimated net worth of $4.31 Million. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., TerraVia Holdings, Inc., and Oruka Therapeutics, Inc..

2012 was Paul T Quinlan's most active year for acquiring shares with 14 total transactions. Paul T Quinlan's most active month to acquire stocks was the month of January. 2012 was Paul T Quinlan's most active year for disposing of shares, totalling 27 transactions. Paul T Quinlan's most active month to dispose stocks was the month of February. 2024 saw Paul T Quinlan paying a total of $344,691.36 for 180,887 shares, this is the most they've acquired in one year. In 2023 Paul T Quinlan cashed out on 176,000 shares for a total of $1,380,411.80, their largest year based on trade value.